Erivedge Capsule
Product Images NDC 50242-140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erivedge (NDC 50242-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Erivedge 01)

Chemical Structure (Erivedge 01)
Chemical structure of vismodegib, the active ingredient in ERIVEDGE. The diagram shows its molecular composition, including chlorine atoms, a pyridine ring, and sulfone group connected through amide and aromatic linkages.*
FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Carton)

Principal Display Panel (150 mg Capsule Bottle Carton)
Label for ERIVEDGE (vismodegib) capsules, 150 mg strength. The label indicates each capsule contains 150 mg of vismodegib. It includes an instruction for pharmacists to dispense the accompanying Medication Guide with each patient. The package contains 28 capsules and is labeled by Genentech, Inc. It also shows the product NDC 50242-140-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.